Research Strategy

Bridging Medical Research and Health

The Kolling Research Strategy 2021-2025 is strengthening our ability to achieve ground-breaking research, while delivering new opportunities and greater assistance to our teams.

The research strategy is focusing on areas of strength, drawing upon the expertise and resources of the University of Sydney and the Northern Sydney Local Health District, and positioning the institute as a hub of translational research excellence.

Researchers are supported to translate scientific discoveries into positive outcomes for clinical practice and community health.

Priority Research Areas

Musculoskeletal – Neuroscience and Pain – Cardiovascular and Renal Research

These areas of research investigate some of the biggest health challenges of our time. Collectively, they cost the community billions of dollars a year in health, personal and economic costs.

Kolling Institute researchers are well respected, with unique skills and knowledge, strong industry links and a track record of success.

They are well placed to strengthen their international, government and industry collaborations, and increase the impact of their research.

Musculoskeletal

Neuroscience and Pain

Cardiovascular and Renal

Research Enablers

A key component of the Kolling Institute’s Research Strategy is the provision of four Kolling research enablers. These will provide research teams with new opportunities, modern platforms and infrastructure, increasing competitiveness, career development and core facility support.